Helen Torley - 20 Feb 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
20 Feb 2025
Net transactions value
$0
Form type
4
Filing time
21 Feb 2025, 18:47:30 UTC
Previous filing
18 Feb 2025
Next filing
24 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Option to Purchase Common Stock Award $0 +71,038 $0.000000 71,038 20 Feb 2025 Common Stock 71,038 $57.44 Direct F1
transaction HALO Restricted Stock Units Award $0 +67,027 $0.000000 67,027 20 Feb 2025 Common Stock 67,027 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F2 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.